Insys Therapeutics Inc - Strategic SWOT Analysis Review

Insys Therapeutics Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the companys history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the companys key employees, key competitors and major products and services.

This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Scope

- Business description A detailed description of the companys operations and business divisions.
- Corporate strategy summarization of the companys business strategy.
- SWOT analysis A detailed analysis of the companys strengths, weakness, opportunities and threats.
- Company history Progression of key events associated with the company.
- Major products and services A list of major products, services and brands of the company.
- Key competitors A list of key competitors to the company.
- Key employees A list of the key executives of the company.
- Executive biographies A brief summary of the executives employment history.
- Key operational heads A list of personnel heading key departments/functions.
- Important locations and subsidiaries A list of key locations and subsidiaries of the company, including contact details.

Highlights

Insys Therapeutics Inc (Insys) is a specialty pharmaceutical company, which discovers, develops and commercializes novel drug delivery systems of therapeutic compounds. The company harnesses its proprietary sublingual spray technology to develop pharmaceutical cannabinoids. Its marketed products inlcude Subsys, a sublingual fentanyl spray for breakthrough cancer pain (BTCP) and Syndros (dronabinol oral solution), an orally administered liquid formulation of dronabinol for the treatment of chemotherapy-induced nausea and vomiting (CINV) and anorexia associated with weight loss in AIDS patients. The company offers its products to oncologists, pain specialists and supportive care centers for the potential treatment of addiction to opioids, opioid overdose and epilepsy. It has operations in the US and offers its products in international markets. Insys is headquartered in Chandler, Arizona, the US.

Insys Therapeutics Inc Key Recent Developments

Jun 27,2019: Insys Therapeutics becomes first Opioid Company to Declare Bankruptcy
Jun 10,2019: INSYS Therapeutics initiates court-supervised process to facilitate asset sales and address legacy liabilities
May 10,2019: INSYS Therapeutics reports first quarter 2019 results
Apr 15,2019: INSYS Therapeutics Implements Leadership Changes
Mar 07,2019: INSYS Therapeutics reports fourth quarter and full year 2018 results

Reasons to Buy

- Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
- Identify potential customers and suppliers with this reports analysis of the companys business structure, operations, major products and services and business strategy.
- Understand and respond to your competitors business structure and strategies with detailed SWOT analysis. In this, the companys core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
- Examine potential investment and acquisition targets with this reports detailed insight into the companys strategic, business and operational performance.

Note: Some sections may be missing if data is unavailable for the company.



List of Figures
Section 1 - About the Company
Insys Therapeutics Inc - Key Facts
Insys Therapeutics Inc - Key Employees
Insys Therapeutics Inc - Key Employee Biographies
Insys Therapeutics Inc - Major Products and Services
Insys Therapeutics Inc - History
Insys Therapeutics Inc - Company Statement
Insys Therapeutics Inc - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 Company Analysis
Company Overview
Insys Therapeutics Inc - Business Description
Insys Therapeutics Inc - Corporate Strategy
Insys Therapeutics Inc - SWOT Analysis
SWOT Analysis - Overview
Insys Therapeutics Inc - Strengths
Insys Therapeutics Inc - Weaknesses
Insys Therapeutics Inc - Opportunities
Insys Therapeutics Inc - Threats
Insys Therapeutics Inc - Key Competitors
Section 3 Companys Lifesciences Financial Deals and Alliances
Insys Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Insys Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Type, 2014 to YTD 2020
Insys Therapeutics Inc, Recent Deals Summary
Section 4 Companys Recent Developments
Jun 27, 2019: Insys Therapeutics becomes first Opioid Company to Declare Bankruptcy
Jun 10, 2019: INSYS Therapeutics initiates court-supervised process to facilitate asset sales and address legacy liabilities
May 10, 2019: INSYS Therapeutics reports first quarter 2019 results
Apr 15, 2019: INSYS Therapeutics Implements Leadership Changes
Mar 07, 2019: INSYS Therapeutics reports fourth quarter and full year 2018 results
Section 5 Appendix
Methodology
About GlobalData
Contact Us
Disclaimer

List Of Tables


Insys Therapeutics Inc, Key Facts
Insys Therapeutics Inc, Key Employees
Insys Therapeutics Inc, Key Employee Biographies
Insys Therapeutics Inc, Major Products and Services
Insys Therapeutics Inc, History
Insys Therapeutics Inc, Other Locations
Insys Therapeutics Inc, Subsidiaries
Insys Therapeutics Inc, Key Competitors
Insys Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Insys Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Type, 2014 to YTD 2020
Insys Therapeutics Inc, Recent Deals Summary

List Of Figures


Insys Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Insys Therapeutics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2014 to YTD 2020

Insys Therapeutics Inc - Strategic SWOT Analysis Review

Insys Therapeutics Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the companys history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information

USD 125 View Report

Insys Therapeutics Inc (INSY) - Financial and Strategic SWOT Analysis Review

Insys Therapeutics Inc (INSY) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the companys businesses and operations. The profile has been compiled to

USD 125 View Report

Anika Therapeutics Inc (ANIK) - Product Pipeline Analysis, 2021 Update

Anika Therapeutics Inc (Anika) develops, manufactures, and markets therapeutic products for degenerative orthopedic diseases and traumatic conditions. It offers solutions for ortho-biologics, dermal, ophthalmic, surgical and veterinary applications. Its major

USD 750 View Report

Chinook Therapeutics Inc (KDNY) - Financial and Strategic SWOT Analysis Review

Chinook Therapeutics, Inc (Chinook)., formerly Aduro BioTech Inc is a clinical-stage immunotherapy company that discovers, develops and commercializes therapies for the treatment of cancer. The company develops product candidates using

USD 300 View Report

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available